Showing results (461-470 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|December 22, 2009
Ephrin expression and function in cancerJennifer K McCarron, Brett W Stringer, Bryan W Day, et al.
Future Oncology (London, England)|May 4, 2018
Statins use and cancer: an updateMartyna Zaleska, Olga Mozenska, Jacek Bil
Future Oncology (London, England)|May 2, 2018
Overexpression of p21-activated kinase 2 is correlated with high-grade oral squamous cell carcinomasYao Xiao, Wei-Wei Deng, Lei-Lei Yang, et al.
Future Oncology (London, England)|May 5, 2018
Management and grading of EGFR inhibitor-induced cutaneous toxicityJanette Beech, Theodora Germetaki, Mary Judge, et al.
Future Oncology (London, England)|June 2, 2018
Talking to patients about biosimilarsYelena Y Janjigian, Marco Bissig, Giuseppe Curigliano, et al.
Future Oncology (London, England)|April 18, 2018
Tailored management of stage IIIa non-small-cell lung cancer in the era of the 8th edition of the TNM classification for lung cancerMichael R Mueller
Future Oncology (London, England)|April 18, 2018
Combined taxane-based chemotherapy and intensity-modulated radiotherapy with simultaneous integrated boost for gastroesophageal junction adenocarcinomaCorrado Spatola, Alessandra Tocco, Antonio Pagana, et al.
Future Oncology (London, England)|April 18, 2018
2016 Annual report from the Italian VATS GroupPiergiorgio Solli, Luca Bertolaccini, Andrea Droghetti, et al.
Future Oncology (London, England)|April 26, 2018
Bevacizumab biosimilars: scientific justification for extrapolation of indicationsBarbara Melosky, David A Reardon, Andrew B Nixon, et al.
Future Oncology (London, England)|May 31, 2018
Treatment patterns and medication adherence among patients diagnosed with multiple myeloma and treated with panobinostatAjai Chari, Menaka Bhor, Lamis Eldjerou, et al.
Pageof 451